C210-0142 Screening compound: N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H,4H-thieno[2,3-d]pyrimidin-3-yl)acetamide

C210-0142 Screening compound: N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H,4H-thieno[2,3-d]pyrimidin-3-yl)acetamide
C210-0142 Screening compound: N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H,4H-thieno[2,3-d]pyrimidin-3-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C210-0142
N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H,4H-thieno[2,3-d]pyrimidin-3-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C210-0142

Molecular Formula

C27H31N7O5S2 (C27 H31 N7 O5 S2)

Compound Name

N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H,4H-thieno[2,3-d]pyrimidin-3-yl)acetamide

IUPAC name

N-(4-ethoxyphenyl)-N-ethyl-2-(6-methyl-4-oxo-5-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}-3H4H-thieno[23-d]pyrimidin-3-yl)acetamide

SMILES

CCN(C(CN(C=Nc1c2c(S(N(CC3)CCN3c3ncccn3)(=O)=O)c(C)s1)C2=O)=O)c(cc1)ccc1OCC

InChI

InChI=1S/C27H31N7O5S2/c1-4-34(20-7-9-21(10-8-20)39-5-2)22(35)17-32-18-30-25-23(26(32)36)24(19(3)40-25)41(37,38)33-15-13-31(14-16-33)27-28-11-6-12-29-27/h6-12,18H,4-5,13-17H2,1-3H3

InChI Key

MLJJZUFSBLGPIS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14732394

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

597.72

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

2.549

Distribution Coefficient, logD

2.549

Water Solubility, LogSw

-2.70

Polar Surface Area

101.790

Acid Dissociation Constant (pKa)

20.87

Base Dissociation Constant (pKb)

3.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

C210-0142 in Drug Discovery

Included in Screening Libraries

Human Receptors Annotated Library (5376 compounds)

MCL1 Targeted Library (12200 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with C210-0142 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C210-0142?
Check Price and Availability of C210-0142, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C210-0142 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C210-0142
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C210-0142
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C210-0142 available by request